Display options
Cite
Awwad MHS, Kriegsmann K, Plaumann J, et al. The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma. Oncoimmunology. 2018;7(10):e1486356doi: 10.1080/2162402X.2018.1486356.
Awwad, M. H. S., Kriegsmann, K., Plaumann, J., Benn, M., Hillengass, J., Raab, M. S., Bertsch, U., Munder, M., Weisel, K., Salwender, H. J., Hänel, M., Fenk, R., Dürig, J., Müller-Tidow, C., Goldschmidt, H., & Hundemer, M. (2018). The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma. Oncoimmunology, 7(10), e1486356. https://doi.org/10.1080/2162402X.2018.1486356
Awwad, Mohamed H S, et al. "The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma." Oncoimmunology vol. 7,10 (2018): e1486356. doi: https://doi.org/10.1080/2162402X.2018.1486356
Awwad MHS, Kriegsmann K, Plaumann J, Benn M, Hillengass J, Raab MS, Bertsch U, Munder M, Weisel K, Salwender HJ, Hänel M, Fenk R, Dürig J, Müller-Tidow C, Goldschmidt H, Hundemer M. The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma. Oncoimmunology. 2018 Aug 01;7(10):e1486356. doi: 10.1080/2162402X.2018.1486356. eCollection 2018. PMID: 30288348; PMCID: PMC6169592.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2018 Aug 01;7(10):e1486356. doi: 10.1080/2162402X.2018.1486356. eCollection 2018.

The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.

Oncoimmunology

Mohamed H S Awwad, Katharina Kriegsmann, Julian Plaumann, Michael Benn, Jens Hillengass, Marc S Raab, Uta Bertsch, Markus Munder, Katja Weisel, Hans Jürgen Salwender, Mathias Hänel, Roland Fenk, Jan Dürig, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Hundemer

Affiliations

  1. Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  2. National Center for Tumour Diseases, University of Heidelberg, Heidelberg, Germany.
  3. Department of Hematology, Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  4. Department of Hematology, Oncology, Immunology and Rheumatology, University of Tübingen, Tübingen, Germany.
  5. Asklepios Klinik Hamburg Altona, Germany.
  6. Klinikum Chemnitz, Germany.
  7. Department of Hematology, Oncology and Clinical Immunology, University Düsseldorf, Düsseldorf, Germany.
  8. Department of Hematology, University of Essen, Essen, Germany.

PMID: 30288348 PMCID: PMC6169592 DOI: 10.1080/2162402X.2018.1486356

[No abstract available.]

Keywords: IKZF1; IKZF3; Multiple myeloma; T cells; biomarker trials; immune; immunomodulatory drugs

References

  1. Blood. 2015 Jun 25;125(26):4042-51 - PubMed
  2. J Hematol Oncol. 2016 Nov 21;9(1):123 - PubMed
  3. Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18072-7 - PubMed
  4. Leukemia. 2017 Jun;31(6):1363-1367 - PubMed
  5. Cell Death Differ. 2016 Jul;23(7):1175-84 - PubMed
  6. PLoS One. 2013 Aug 19;8(8):e71302 - PubMed
  7. Sci Signal. 2014 Mar 18;7(317):ra28 - PubMed
  8. Leukemia. 2016 Jun;30(6):1436-40 - PubMed
  9. Blood. 2010 Oct 28;116(17):3227-37 - PubMed
  10. Am J Hematol. 2016 Nov;91(11):E473-E477 - PubMed
  11. Exp Hematol. 2006 Apr;34(4):486-96 - PubMed
  12. J Immunol. 2007 Dec 1;179(11):7305-15 - PubMed
  13. Mol Cell Biol. 2006 Jan;26(1):209-20 - PubMed
  14. Science. 2014 Jan 17;343(6168):301-5 - PubMed
  15. Best Pract Res Clin Haematol. 2007 Dec;20(4):681-99 - PubMed
  16. J Immunol. 2011 Jul 15;187(2):1047-56 - PubMed
  17. Haematologica. 2017 Jul;102(7):1281-1290 - PubMed
  18. J Cell Sci. 2007 Aug 1;120(Pt 15):2619-30 - PubMed
  19. Mol Cell Biol. 2004 Apr;24(7):2797-807 - PubMed
  20. Curr Biol. 1998 Apr 23;8(9):508-15 - PubMed
  21. Am J Hematol. 2017 Mar;92(3):269-278 - PubMed
  22. Blood. 2007 Apr 1;109(7):2878-86 - PubMed
  23. N Engl J Med. 2007 Nov 22;357(21):2123-32 - PubMed
  24. J Immunother. 2009 Jul-Aug;32(6):613-21 - PubMed
  25. Blood. 2014 Jul 24;124(4):536-45 - PubMed

Publication Types